Content Validity of the Hypogonadism Impact of Symptoms Questionnaire (HIS-Q): A Patient-Reported Outcome Measure to Evaluate Symptoms of Hypogonadism

Heather L. Gelhorn, Margaret K. Vernon, Katie D. Stewart, Michael G. Miller, Meryl Brod, Stanley E. Althof, Leonard Derogatis, Adrian S Dobs, Allen D. Seftel, Dennis A. Revicki

Research output: Contribution to journalArticle

Abstract

Background: Hypogonadism, or low testosterone, is a common disorder. There are currently no patient-reported outcome (PRO) instruments designed to comprehensively evaluate the symptoms of hypogonadism and to detect changes in these symptoms in response to treatment. Objective: The purpose of this study was to develop a PRO instrument, the Hypogonadism Impact of Symptoms Questionnaire (HIS-Q) and to assess its content validity. Methods: A literature review, expert clinician input, and qualitative concept elicitation with 39 male hypogonadism patients (four focus groups: n = 25; individual interviews: n = 14; mean age 52.3 ± 14.3 years) from the USA were used to develop the draft HIS-Q. Subsequent cognitive interviews (n = 29; mean age 51.5 ± 15.4 years) were used to evaluate content validity. Results: Emergent discussion with participants yielded symptoms within the sexual, physical, energy, sleep, cognition, and mood domains. Low libido and tiredness were most commonly reported. The initial version of the HIS-Q includes 53 items that were consistently understood by the participants, who found the instrument to be relevant to their experiences with hypogonadism and comprehensive in the content coverage of symptoms. Conclusion: The HIS-Q is a comprehensive PRO measure of hypogonadism symptom severity in males. Its design elements, including the response options and recall period, were suitable, and content validity was confirmed.

Original languageEnglish (US)
Pages (from-to)181-190
Number of pages10
JournalPatient
Volume9
Issue number2
DOIs
StatePublished - Apr 1 2016

Fingerprint

Hypogonadism
Eunuchism
Interviews
Libido
Response Elements
Surveys and Questionnaires
Patient Reported Outcome Measures
Focus Groups
Cognition
Testosterone
Sleep

ASJC Scopus subject areas

  • Nursing (miscellaneous)

Cite this

Gelhorn, H. L., Vernon, M. K., Stewart, K. D., Miller, M. G., Brod, M., Althof, S. E., ... Revicki, D. A. (2016). Content Validity of the Hypogonadism Impact of Symptoms Questionnaire (HIS-Q): A Patient-Reported Outcome Measure to Evaluate Symptoms of Hypogonadism. Patient, 9(2), 181-190. https://doi.org/10.1007/s40271-015-0138-8

Content Validity of the Hypogonadism Impact of Symptoms Questionnaire (HIS-Q) : A Patient-Reported Outcome Measure to Evaluate Symptoms of Hypogonadism. / Gelhorn, Heather L.; Vernon, Margaret K.; Stewart, Katie D.; Miller, Michael G.; Brod, Meryl; Althof, Stanley E.; Derogatis, Leonard; Dobs, Adrian S; Seftel, Allen D.; Revicki, Dennis A.

In: Patient, Vol. 9, No. 2, 01.04.2016, p. 181-190.

Research output: Contribution to journalArticle

Gelhorn, Heather L. ; Vernon, Margaret K. ; Stewart, Katie D. ; Miller, Michael G. ; Brod, Meryl ; Althof, Stanley E. ; Derogatis, Leonard ; Dobs, Adrian S ; Seftel, Allen D. ; Revicki, Dennis A. / Content Validity of the Hypogonadism Impact of Symptoms Questionnaire (HIS-Q) : A Patient-Reported Outcome Measure to Evaluate Symptoms of Hypogonadism. In: Patient. 2016 ; Vol. 9, No. 2. pp. 181-190.
@article{330cc9f23a654db1b53197c6c8a77773,
title = "Content Validity of the Hypogonadism Impact of Symptoms Questionnaire (HIS-Q): A Patient-Reported Outcome Measure to Evaluate Symptoms of Hypogonadism",
abstract = "Background: Hypogonadism, or low testosterone, is a common disorder. There are currently no patient-reported outcome (PRO) instruments designed to comprehensively evaluate the symptoms of hypogonadism and to detect changes in these symptoms in response to treatment. Objective: The purpose of this study was to develop a PRO instrument, the Hypogonadism Impact of Symptoms Questionnaire (HIS-Q) and to assess its content validity. Methods: A literature review, expert clinician input, and qualitative concept elicitation with 39 male hypogonadism patients (four focus groups: n = 25; individual interviews: n = 14; mean age 52.3 ± 14.3 years) from the USA were used to develop the draft HIS-Q. Subsequent cognitive interviews (n = 29; mean age 51.5 ± 15.4 years) were used to evaluate content validity. Results: Emergent discussion with participants yielded symptoms within the sexual, physical, energy, sleep, cognition, and mood domains. Low libido and tiredness were most commonly reported. The initial version of the HIS-Q includes 53 items that were consistently understood by the participants, who found the instrument to be relevant to their experiences with hypogonadism and comprehensive in the content coverage of symptoms. Conclusion: The HIS-Q is a comprehensive PRO measure of hypogonadism symptom severity in males. Its design elements, including the response options and recall period, were suitable, and content validity was confirmed.",
author = "Gelhorn, {Heather L.} and Vernon, {Margaret K.} and Stewart, {Katie D.} and Miller, {Michael G.} and Meryl Brod and Althof, {Stanley E.} and Leonard Derogatis and Dobs, {Adrian S} and Seftel, {Allen D.} and Revicki, {Dennis A.}",
year = "2016",
month = "4",
day = "1",
doi = "10.1007/s40271-015-0138-8",
language = "English (US)",
volume = "9",
pages = "181--190",
journal = "Patient",
issn = "1178-1653",
publisher = "Springer Science + Business Media",
number = "2",

}

TY - JOUR

T1 - Content Validity of the Hypogonadism Impact of Symptoms Questionnaire (HIS-Q)

T2 - A Patient-Reported Outcome Measure to Evaluate Symptoms of Hypogonadism

AU - Gelhorn, Heather L.

AU - Vernon, Margaret K.

AU - Stewart, Katie D.

AU - Miller, Michael G.

AU - Brod, Meryl

AU - Althof, Stanley E.

AU - Derogatis, Leonard

AU - Dobs, Adrian S

AU - Seftel, Allen D.

AU - Revicki, Dennis A.

PY - 2016/4/1

Y1 - 2016/4/1

N2 - Background: Hypogonadism, or low testosterone, is a common disorder. There are currently no patient-reported outcome (PRO) instruments designed to comprehensively evaluate the symptoms of hypogonadism and to detect changes in these symptoms in response to treatment. Objective: The purpose of this study was to develop a PRO instrument, the Hypogonadism Impact of Symptoms Questionnaire (HIS-Q) and to assess its content validity. Methods: A literature review, expert clinician input, and qualitative concept elicitation with 39 male hypogonadism patients (four focus groups: n = 25; individual interviews: n = 14; mean age 52.3 ± 14.3 years) from the USA were used to develop the draft HIS-Q. Subsequent cognitive interviews (n = 29; mean age 51.5 ± 15.4 years) were used to evaluate content validity. Results: Emergent discussion with participants yielded symptoms within the sexual, physical, energy, sleep, cognition, and mood domains. Low libido and tiredness were most commonly reported. The initial version of the HIS-Q includes 53 items that were consistently understood by the participants, who found the instrument to be relevant to their experiences with hypogonadism and comprehensive in the content coverage of symptoms. Conclusion: The HIS-Q is a comprehensive PRO measure of hypogonadism symptom severity in males. Its design elements, including the response options and recall period, were suitable, and content validity was confirmed.

AB - Background: Hypogonadism, or low testosterone, is a common disorder. There are currently no patient-reported outcome (PRO) instruments designed to comprehensively evaluate the symptoms of hypogonadism and to detect changes in these symptoms in response to treatment. Objective: The purpose of this study was to develop a PRO instrument, the Hypogonadism Impact of Symptoms Questionnaire (HIS-Q) and to assess its content validity. Methods: A literature review, expert clinician input, and qualitative concept elicitation with 39 male hypogonadism patients (four focus groups: n = 25; individual interviews: n = 14; mean age 52.3 ± 14.3 years) from the USA were used to develop the draft HIS-Q. Subsequent cognitive interviews (n = 29; mean age 51.5 ± 15.4 years) were used to evaluate content validity. Results: Emergent discussion with participants yielded symptoms within the sexual, physical, energy, sleep, cognition, and mood domains. Low libido and tiredness were most commonly reported. The initial version of the HIS-Q includes 53 items that were consistently understood by the participants, who found the instrument to be relevant to their experiences with hypogonadism and comprehensive in the content coverage of symptoms. Conclusion: The HIS-Q is a comprehensive PRO measure of hypogonadism symptom severity in males. Its design elements, including the response options and recall period, were suitable, and content validity was confirmed.

UR - http://www.scopus.com/inward/record.url?scp=84961199486&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84961199486&partnerID=8YFLogxK

U2 - 10.1007/s40271-015-0138-8

DO - 10.1007/s40271-015-0138-8

M3 - Article

C2 - 26334870

AN - SCOPUS:84961199486

VL - 9

SP - 181

EP - 190

JO - Patient

JF - Patient

SN - 1178-1653

IS - 2

ER -